IRAK4-IN-4

CAS No. 1850276-58-2

IRAK4-IN-4( —— )

Catalog No. M22690 CAS No. 1850276-58-2

IRAK4-IN-4 inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM.IRAK4-IN-4 is an interleukin-1 receptor–associated kinase 4 (IRAK4) inhibitor, has an IC50 of 2.8 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 155 In Stock
5MG 141 In Stock
10MG 212 In Stock
25MG 377 In Stock
50MG 554 In Stock
100MG 798 In Stock
200MG 1070 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    IRAK4-IN-4
  • Note
    Research use only, not for human use.
  • Brief Description
    IRAK4-IN-4 inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM.IRAK4-IN-4 is an interleukin-1 receptor–associated kinase 4 (IRAK4) inhibitor, has an IC50 of 2.8 nM.
  • Description
    IRAK4-IN-4 inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM.IRAK4-IN-4 is an interleukin-1 receptor–associated kinase 4 (IRAK4) inhibitor, has an IC50 of 2.8 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    IRAK4|cGAS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1850276-58-2
  • Formula Weight
    340.37
  • Molecular Formula
    C22H16N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:24 mg/mL(70.51 mM)
  • SMILES
    Cc1ccn2c(C(=O)C(=O)c3ccccc3)c(nc2c1)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.One class has the naphthalene second dione compounds and its derivative of protease modification activities. CN107163044A.
molnova catalog
related products
  • 3-Methoxyphenylaceti...

    3-Methoxyphenylacetic acid belongs to the class of organic compounds known as anisoles.?3-Methoxyphenylacetic acid is slightly soluble (in water) and a weakly acidic compound (based on its pKa).

  • NSC2805

    NSC2805 is an inhibitor of WWP2, an E3 ubiquitin ligase with an IC50 of 0.38 μM. NSC2805 can be used in anticancer studies.

  • Clozic

    Clozic exhibits reversible anti-proliferative effects and can be used in studies about serving as a potential anti-arthritic agent.